Valley National Advisers Inc. Buys 394 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Valley National Advisers Inc. grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 10.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,182 shares of the financial services provider’s stock after purchasing an additional 394 shares during the quarter. Valley National Advisers Inc.’s holdings in iShares Biotechnology ETF were worth $552,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the stock. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $30,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Modus Advisors LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth $41,000. Finally, Crews Bank & Trust purchased a new position in iShares Biotechnology ETF in the fourth quarter worth $44,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.2 %

Shares of iShares Biotechnology ETF stock opened at $138.66 on Monday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock has a fifty day moving average price of $136.37 and a 200-day moving average price of $141.55.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.